Practical Solutions to Prevent and Prepare for Severe Hypoglycemia
| Overview / Abstract: |
Episodes of hypoglycemia, including those that are severe, still occur despite new pharmacotherapies and the increased use of continuous glucose monitoring. Do you know which of your patients are at risk? Are they prepared with an active glucagon prescription? This activity helps you identify at risk patients and ensure they are prepared with access to glucagon. Included with the education are tools to educate patients and establish processes to improve hypoglycemia recognition and success with glucagon administration. Hypoglycemia is a common complication of treatment that negatively impacts quality of life and elicits fears in patients with diabetes. Severe episodes, in which the person requires assistance from others, can have negative health consequences such as increased mortality. Identifying patients who are at risk for severe episodes and making sure they and their caregivers are prepared can improve outcomes. Yet, many patients are not prepared, and guideline-recommended glucagon is under prescribed in eligible patients. |
|
Expiration |
Sep 09, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
1.0 |
|
Accreditation |
ACCME, ANCC, ACPE, MOC, AANP, AAPA, MIPS QPP |
|
Presenters / Authors / Faculty |
Davida F. Kruger, MSN, APN-BC, BC-ADM Anne Louise Peters, MD |
|
Activity Specialities / Related Topics |
Endocrinology, Family Medicine, Internal Medicine, Primary Care |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Lilly. |
|
Keywords / Search Terms |
ACHL CME, CE, CPE, Davida Kruger, Anne Peters, Purdue, ACHL, Hypoglycemia, Lilly, Glucose, insulin, T2D, T2DM, T1DM, diabetes, type 2, sulfonylurea, Helmsley Registry, HbA1c, HypoA-Q, HRQoL, UKPDS, ADA, Rule of 15, case study, patient, Baqsimi, glucagon, Zegalogue, Gvoke, Intranasal powder device, Intranasal, Intramuscular, IV Insulin Free CE CME |
|